Position in BMY
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$175,349,471
-$4,276,359 QoQ
Shares Held
3,043,205
+2.8% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#77
of 2,506 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swedbank AB holds $5,796,975,204 across 10 Drug Manufacturers - General names. BMY ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,781,310 | $2,136,556,831 | |
| 2 | JNJ |
Johnson & Johnson
|
3,624,513 | $920,517,565 | |
| 3 | MRK |
Merck & Co., Inc.
|
6,360,649 | $817,343,396 | |
| 4 | ABBV |
AbbVie Inc.
|
2,634,628 | $662,977,789 | |
| 5 | AZN |
Astrazeneca PLC
|
2,241,677 | $425,066,792 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,903,177 | $240,447,381 | |
| 7 | AMGN |
Amgen Inc
|
517,466 | $187,384,787 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
3,043,205 | $175,349,471 |
All Filings in BMY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,349,471 | 3,043,205 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $179,625,830 | 2,961,679 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $160,709,537 | 2,979,413 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $134,120,228 | 2,973,841 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $136,936,465 | 2,958,230 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $180,181,720 | 3,185,674 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $162,440,420 | 3,139,552 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $129,205,021 | 3,111,125 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $158,221,124 | 2,917,639 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $108,465,081 | 2,113,917 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $122,514,197 | 2,110,858 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $134,806,088 | 2,107,992 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $146,870,730 | 2,119,041 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $147,870,272 | 2,055,181 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $140,173,982 | 1,971,782 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $152,081,622 | 1,975,086 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $149,472,326 | 2,046,725 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $126,333,694 | 2,026,202 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $118,269,706 | 1,998,812 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $130,173,111 | 1,948,116 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $116,078,141 | 1,838,716 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||